The Agreement contains certain termination rights for both the Company and Parent, including if the Transaction is not completed on or before October 9, 2025, subject in certain circumstances to automatic extension in two three month increments to April 9, 2026 if certain regulatory approvals have not been obtained. The Agreement provides that, if the Agreement is terminated, the Company will pay a $200 million termination fee to the Parent in the case of certain events described in the Agreement, including if the Company terminates the Agreement in connection with the Company Board changing its recommendation and if the Parent terminates the Agreement due to the Company Board changing its recommendation. The termination fee may also become payable by the Company if the Agreement is terminated in certain circumstances and the Company enters into an agreement for an alternative transaction within twelve months of such termination.What if lithium prices go up 15% -25% before 2025
- Forums
- ASX - By Stock
- Ann: RIO: Rio Tinto confirms approach to Arcadium Lithium
The Agreement contains certain termination rights for both the...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LTM (ASX) to my watchlist
(20min delay)
|
|||||
Last
$8.06 |
Change
-0.080(0.98%) |
Mkt cap ! $2.361B |
Open | High | Low | Value | Volume |
$8.11 | $8.14 | $8.06 | $11.47M | 1.419M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 351382 | $8.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.08 | 1700 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 351382 | 8.060 |
3 | 5504 | 8.050 |
1 | 3000 | 8.030 |
2 | 3500 | 8.020 |
7 | 8959 | 8.000 |
Price($) | Vol. | No. |
---|---|---|
8.080 | 1700 | 1 |
8.100 | 9560 | 2 |
8.120 | 11000 | 2 |
8.130 | 690 | 2 |
8.140 | 5763 | 2 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
LTM (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online